CL2021000329A1 - Compuestos útiles en terapia del vih - Google Patents
Compuestos útiles en terapia del vihInfo
- Publication number
- CL2021000329A1 CL2021000329A1 CL2021000329A CL2021000329A CL2021000329A1 CL 2021000329 A1 CL2021000329 A1 CL 2021000329A1 CL 2021000329 A CL2021000329 A CL 2021000329A CL 2021000329 A CL2021000329 A CL 2021000329A CL 2021000329 A1 CL2021000329 A1 CL 2021000329A1
- Authority
- CL
- Chile
- Prior art keywords
- useful compounds
- hiv therapy
- compounds
- hiv
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La invención se refiere a compuestos de las fórmulas (I), (Ia), (II) y (IIa), sales de los mismos, composiciones farmacéuticas de los mismos, así como procedimientos para tratar o prevenir el VIH en sujetos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862716494P | 2018-08-09 | 2018-08-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2021000329A1 true CL2021000329A1 (es) | 2021-09-03 |
Family
ID=68072882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2021000329A CL2021000329A1 (es) | 2018-08-09 | 2021-02-08 | Compuestos útiles en terapia del vih |
Country Status (15)
Country | Link |
---|---|
US (1) | US20220117993A1 (es) |
EP (1) | EP3833437A1 (es) |
JP (1) | JP2021534112A (es) |
KR (1) | KR20210044806A (es) |
CN (1) | CN112789085A (es) |
AR (1) | AR115936A1 (es) |
AU (1) | AU2019317810A1 (es) |
BR (1) | BR112021002169A2 (es) |
CA (1) | CA3108635A1 (es) |
CL (1) | CL2021000329A1 (es) |
IL (1) | IL280660A (es) |
MA (1) | MA53280A (es) |
MX (1) | MX2021001612A (es) |
TW (1) | TW202023650A (es) |
WO (1) | WO2020031131A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020154656A1 (en) | 2019-01-25 | 2020-07-30 | Brown University | Compositions and methods for treating, preventing or reversing age-associated inflammation and disorders |
US20220259252A1 (en) * | 2019-08-08 | 2022-08-18 | Glaxosmithkline Intellectual Property (No.2) Limited | 4'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapy |
CN115605493A (zh) | 2020-03-20 | 2023-01-13 | 吉利德科学公司(Us) | 4′-c-取代的-2-卤代-2′-脱氧腺苷核苷的前药及其制备和使用方法 |
EP4281081A1 (en) * | 2021-01-25 | 2023-11-29 | Brii Biosciences, Inc. | Adenosine derivative and pharmaceutical composition comprising the same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB427857A (en) | 1934-08-02 | 1935-05-01 | Newsum Sons & Company Ltd H | A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames |
US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
KR20030093248A (ko) | 2001-03-19 | 2003-12-06 | 오노 야꾸힝 고교 가부시키가이샤 | 트리아자스피로[5.5]운데칸 유도체를 유효성분으로서함유하는 약제 |
CA2502109C (en) * | 2004-03-24 | 2010-02-23 | Yamasa Corporation | 4'-c-substituted-2-haloadenosine derivative |
MX2009012433A (es) * | 2007-05-14 | 2010-04-30 | Rfs Pharma Llc | Azido nucleosidos de purina para el tratamiento de infecciones virales. |
WO2015143712A1 (en) * | 2014-03-28 | 2015-10-01 | Merck Sharp & Dohme Corp. | 4'-substituted nucleoside reverse transcriptase inhibitors |
US9822138B2 (en) * | 2015-08-10 | 2017-11-21 | Merck Sharp & Dohme Corp. | Antiviral beta-amino acid ester phosphodiamide compounds |
US20190185508A1 (en) * | 2017-12-15 | 2019-06-20 | Merck Sharp & Dohme Corp. | Deuterated nucleoside reverse transcriptase inhibitors |
-
2019
- 2019-08-08 TW TW108128258A patent/TW202023650A/zh unknown
- 2019-08-08 CA CA3108635A patent/CA3108635A1/en not_active Abandoned
- 2019-08-08 EP EP19779131.2A patent/EP3833437A1/en not_active Withdrawn
- 2019-08-08 JP JP2021506694A patent/JP2021534112A/ja active Pending
- 2019-08-08 AR ARP190102256A patent/AR115936A1/es unknown
- 2019-08-08 MX MX2021001612A patent/MX2021001612A/es unknown
- 2019-08-08 US US17/266,675 patent/US20220117993A1/en not_active Abandoned
- 2019-08-08 AU AU2019317810A patent/AU2019317810A1/en not_active Abandoned
- 2019-08-08 WO PCT/IB2019/056761 patent/WO2020031131A1/en active Application Filing
- 2019-08-08 BR BR112021002169-8A patent/BR112021002169A2/pt not_active Application Discontinuation
- 2019-08-08 CN CN201980066756.7A patent/CN112789085A/zh active Pending
- 2019-08-08 MA MA053280A patent/MA53280A/fr unknown
- 2019-08-08 KR KR1020217006489A patent/KR20210044806A/ko unknown
-
2021
- 2021-02-04 IL IL280660A patent/IL280660A/en unknown
- 2021-02-08 CL CL2021000329A patent/CL2021000329A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2019317810A1 (en) | 2021-02-25 |
US20220117993A1 (en) | 2022-04-21 |
AR115936A1 (es) | 2021-03-17 |
IL280660A (en) | 2021-03-25 |
MA53280A (fr) | 2021-11-17 |
WO2020031131A1 (en) | 2020-02-13 |
BR112021002169A2 (pt) | 2021-05-04 |
JP2021534112A (ja) | 2021-12-09 |
CN112789085A (zh) | 2021-05-11 |
KR20210044806A (ko) | 2021-04-23 |
TW202023650A (zh) | 2020-07-01 |
MX2021001612A (es) | 2021-05-13 |
CA3108635A1 (en) | 2020-02-13 |
EP3833437A1 (en) | 2021-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY37710A (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
ECSP20020410A (es) | Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp-1) y usos de los mismos | |
CO2020007218A2 (es) | Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1 | |
CO2019007863A2 (es) | Derivados de benzooxazol como inmunomoduladores | |
UY36648A (es) | Inhibidores de la replicación del virus de inmunodeficiencia humana | |
CL2018003701A1 (es) | Compuestos heterocíclicos como inmunomoduladores. | |
UY36649A (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana | |
CL2021000329A1 (es) | Compuestos útiles en terapia del vih | |
PE20191474A1 (es) | Compuestos de amino-triazolopiridina y su uso en el tratamiento del cancer | |
SV2018005750A (es) | Derivados de compuestos de indol sustituidos como inhibidores de la replicacion virica del dengue | |
CO2018004857A2 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
UY36212A (es) | Moduladores de receptores tipo toll para el tratamiento del vih | |
ECSP18073293A (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue | |
CL2021001388A1 (es) | Compuestos útiles en la terapia para el vih | |
CL2019002240A1 (es) | Dendrímeros terapéuticos. | |
CO2021012579A2 (es) | Compuestos útiles en la terapia del vih | |
UY37742A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
DOP2021000062A (es) | Inhibidores de la replicación del virus de la inmunodeficiencia humana. | |
UY36145A (es) | Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer | |
UY38228A (es) | Compuestos de triazolopirimidina y su uso en el tratamiento del cáncer | |
CR20180091A (es) | 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del vih | |
UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 | |
MX2020004678A (es) | Uso de profarmacos de riluzol para tratar ataxias. | |
ECSP21010874A (es) | Piridopirimidinas como inhibidores del receptor de histamina h4 | |
NI201600091A (es) | UREAS ASIMÉTRICAS p-SUSTITUIDAS Y USOS MÉDICOS DE LAS MISMAS |